- Home
- TTMI vs NAMS Comparison
TTMI vs NAMS Comparison
Compare TTMI & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTMI
- NAMS
- Stock Information
- Founded
- TTMI 1978
- NAMS 2019
- Country
- TTMI United States
- NAMS Netherlands
- Employees
- TTMI N/A
- NAMS N/A
- Industry
- TTMI Electrical Products
- NAMS Biotechnology: Pharmaceutical Preparations
- Sector
- TTMI Technology
- NAMS Health Care
- Exchange
- TTMI Nasdaq
- NAMS Nasdaq
- Market Cap
- TTMI 1.9B
- NAMS 2.2B
- IPO Year
- TTMI 2000
- NAMS N/A
- Fundamental
- Price
- TTMI $29.86
- NAMS $18.11
- Analyst Decision
- TTMI Strong Buy
- NAMS Strong Buy
- Analyst Count
- TTMI 5
- NAMS 6
- Target Price
- TTMI $32.80
- NAMS $42.83
- AVG Volume (30 Days)
- TTMI 865.6K
- NAMS 694.5K
- Earning Date
- TTMI 04-30-2025
- NAMS 05-08-2025
- Dividend Yield
- TTMI N/A
- NAMS N/A
- EPS Growth
- TTMI N/A
- NAMS N/A
- EPS
- TTMI 0.75
- NAMS N/A
- Revenue
- TTMI $2,521,308,000.00
- NAMS $47,140,000.00
- Revenue This Year
- TTMI $10.33
- NAMS N/A
- Revenue Next Year
- TTMI $5.57
- NAMS N/A
- P/E Ratio
- TTMI $39.79
- NAMS N/A
- Revenue Growth
- TTMI 11.65
- NAMS 586.97
- 52 Week Low
- TTMI $15.78
- NAMS $14.06
- 52 Week High
- TTMI $30.41
- NAMS $27.29
- Technical
- Relative Strength Index (RSI)
- TTMI 73.33
- NAMS 47.80
- Support Level
- TTMI $28.12
- NAMS $16.79
- Resistance Level
- TTMI $30.35
- NAMS $19.58
- Average True Range (ATR)
- TTMI 0.71
- NAMS 0.94
- MACD
- TTMI -0.10
- NAMS -0.12
- Stochastic Oscillator
- TTMI 78.70
- NAMS 47.07
About TTMI TTM Technologies Inc.
TTM Technologies Inc manufactures technology solutions, including mission systems, radio frequency (RF) components/RF microwave/microelectronic assemblies, quick-turn and technologically printed circuit boards (PCB). The company is based in the United States and derives roughly half of its revenue domestically. It organizes itself into two segments: printed circuit boards and RF&S Components. The printed circuit boards segment, which contributes the majority of revenue, offers a range of printed circuit boards as well as layout design and simulation, and testing services. TTM Technologies' products are used in manufacturing, networking, telecommunications, computing, aerospace, and medical fields.
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.